IDH2 and central nervous system cancer: Furthermore, decitabine-mediated hypomethylation restores ULBP1 and ULBP3 expression in IDH-mut glioma cells, suggesting a potential method to sensitize IDH-mut gliomas to NK cell-mediated immune surveillance in the clinic [50].